Found: 3
Select item for more details and to access through your institution.
Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 11072, doi. 10.3390/ijms222011072
- By:
- Publication type:
- Article
Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol.
- Published in:
- Molecular Biology Reports, 2013, v. 40, n. 8, p. 5013, doi. 10.1007/s11033-013-2602-7
- By:
- Publication type:
- Article
BRCA1/BRCA2 variants of uncertain significance in clinical practice: A case report.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 15, n. 5, p. N.PAG, doi. 10.3892/mco.2021.2385
- By:
- Publication type:
- Article